Z-1017-2017 Class II Terminated
FDA device recall Z-1017-2017 was initiated by Merge Healthcare, Inc. on Dec 9, 2016 and is designated Class II. Reason for recall: This recall has been initiated due to an issue related to the potential accidental deletion of record(s) by an Eye Station user. The recall status is terminated (terminated Mar 24, 2021). Affected quantity: 1597 (1451 US; 146 OUS).
Recall details
- Product Type
- Devices
- Report Date
- Jan 18, 2017
- Initiation Date
- Dec 9, 2016
- Termination Date
- Mar 24, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1597 (1451 US; 146 OUS)
Product description
Reason for recall
Distribution pattern
US: Alabama, Alaska, Arizona,Arkansas, California,Colorado,Connecticut,Delaware, District of Columbia, Georgia,Hawaii, Idaho, Illinois,Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland,Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Florida, Tennessee, Wyoming. OUS: Czech Republic Algeria Belgium Brazil Canada Denmark France Germany Greece India Israel Italy Korea, Republic of Luxembourg Netherlands Poland Russian Federation Singapore United Kingdom
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1017-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026